|
|
Pulmonary Medicine
Clinical Services
The Pulmonary Medicine Section provides comprehensive clinical care and consultation for children with lung disorders. Care is provided at The Children's Hospital, National Jewish Medical and Research Center and at outreach clinics in Colorado, Wyoming and Montana.
Asthma Program
Director: Gwendolyn S. Kerby, MD; Associate Directors: F. Dan Atkins, MD (Pediatric Allergy), Monica J. Federico, MD (Pediatric Pulmonary)
The Asthma Program is a multidisciplinary service providing comprehensive care for children with asthma in both an inpatient and outpatient setting. The Program's focus is to normalize patient activity by optimizing pharmacologic therapy through extensive patient education, evaluation of contributing factors, including allergy and environmental triggers, and close monitoring of pulmonary function. Additional goals include outreach education for all health care providers and collaboration with National Jewish Medical and Research Center in asthma-oriented research.
Cystic Fibrosis Center
Director: Frank J. Accurso, MD; Associate Directors: David Rodman, MD (Adult Center) and Jeffrey S. Wagener, MD (Pediatric Center and Outreach)
The Cystic Fibrosis Center is a large, nationally recognized clinical and research service providing care throughout the Rocky Mountain Region. Clinical care is provided by an extensive multidisciplinary team located at The Children's Hospital (Pediatric Program), National Jewish Medical and Research Center (Adult Program), University of Colorado Hospital and at several outreach locations in Colorado, Wyoming and Montana (both adult and pediatric). As one of the Therapeutics Development Centers organized by the national Cystic Fibrosis Foundation, the Colorado center is active in all aspects of clinical and basic research. Special clinical and research emphasis is placed on early detection and disease pathophysiology, since Colorado was the first state in North America to develop newborn screening for cystic fibrosis.
Children's Interstitial Lung Disease Program
Program Director: Robin R. Deterding, MD
This clinical and research program focuses on children with complex lung disease, including all types of interstitial lung diseases such as surfactant dysfunction mutations and unique forms of interstitial lung disease (ILD) in young children and teenagers. Respiratory compromise following bone marrow transplantation and connective tissues disease is also of interest. A longitudinal study looking at biomarkers and outcome markers in these conditions is underway. Significant expertise in CT scans, pulmonary function testing (including infants) and international expertise in video-assisted and bronchoscopic lung biopsy in infants and small children creates a unique opportunity for full diagnostic and second opinion evaluations. Specialists in pediatrics, surgery, nursing, social work and respiratory therapy provide expertise with noninvasive ventilation, immunosuppression and special diagnostic techniques, such as lung biopsy in infants and small children. Dr. Deterding is an original member of the Children's Interstitial Lung Disease Foundation (chILD).
Pediatric Heart Lung Center
Director: Steven H. Abman, MD
The Pediatric Heart Lung Center (PHLC) is a multidisciplinary program that provides novel diagnostic and treatment strategies to children with diverse heart and lung disease, especially related to pulmonary hypertension. Members of the PHLC are actively involved in laboratory and clinical research, as well as in providing consultations to children with pulmonary hypertension as inpatients and outpatients. Clinical care is provided by a multidisciplinary group of pulmonary, cardiology and neonatology specialist physicians, nurses and respiratory therapists. Research extends from bench to bedside and focuses on pulmonary hypertension, premature babies, bronchopulmonary dysplasia, acute lung injury and many other diseases.
Cancer Center Proteomics Core Laboratory
Director: Mark W. Duncan, PhD
The Proteomics Laboratory develops and applies proteomics methods to problems in clinical research. Our activities include quantification and characterization of proteins (including their modifications) in complex biological tissues and fluids. Special attention is directed towards proteomics and is aimed at developing improved diagnostic and prognostic approaches, defining underlying mechanisms of disease and identifying new drug targets. Specific areas of clinical research include diabetes; diseases of the lung including cystic fibrosis; lung, prostate, breast and thyroid cancers; and pituitary function.
Pulmonary Diagnostic Center
Co-Directors: Jeffrey S. Wagener, MD, and Gwendolyn S. Kerby, MD
Diagnostic modalities include pulmonary function testing in both older children and infants, bronchoprovocation and exercise testing, flexible bronchoscopy and laryngoscopy, bronchoalveolar lavage and transbronchial biopsy, induced sputum collection and four-channel sleep studies.
Rocky Mountain Pediatric Sleep Disorders Center
Director: Norman Friedman, MD; Associate Director: Keith L. Cavanaugh, MD; Nurse Practitioner/Administrator: Carole E. Kline, RN, MSN, CPNP
The Rocky Mountain Pediatric Sleep Disorders Center is a multidisciplinary program jointly administered by Pediatric Pulmonary and Pediatric Otolaryngology. A wide variety of pediatric sleep disorders is managed, including, but not limited to, central and obstructive apnea, sleep-disordered breathing and hypoventilation. The program includes physicians, nurses and respiratory therapists with special experience in non-invasive ventilation of children. Patients are studied in a state-of-the-art sleep diagnostic laboratory and can be followed in several clinics which focus on family-based care.
|
|
